Deep-Dive Due Diligence AI Generated Probe of Firefly Neuroscience, Inc. Common Stock (AIFF)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These auto-generated reports apply OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


AIFF_OUT_1 [2025-03-20 11:44:59 -0400] 2189 Bytes | 570 tokens | Cum: 570 tkns (7.12% of 8k)
==========================================================================

Listen up, partner—it's 11:44:57 AM on Thursday March 20, 2025 ET (UTC-0400), and I’m revved up about Firefly Neuroscience (AIFF), climbing from 4.82 to 5.7649. This stock is buzzing big-time—do we have a hidden gem, or a flash in the pan? Help me sift through the data!

Here's the first list of news for Firefly Neuroscience:

C1 - Mar-06-25 07:30AM - Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
C2 - Feb-21-25 08:00AM - Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
C3 - Feb-11-25 07:45AM - Firefly Neuroscience Accepted into NVIDIA Connect Program
C4 - Feb-07-25 07:30AM - Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
C5 - Jan-24-25 09:00AM - Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
C6 - Jan-14-25 07:45AM - Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA Platform
C7 - Dec-31-24 09:00AM - Firefly Neuroscience Closes on Financing of up to $12.4 Million
C8 - Dec-04-24 09:00AM - Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Firefly Neuroscience (AIFF)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

AIFF_IN_2 [2025-03-20 11:44:59 -0400] 2 Bytes | 2 tokens | Cum: 572 tkns (7.15% of 8k)
==========================================================================

C6

AIFF_OUT_3 [2025-03-20 11:45:03 -0400] 985 Bytes | 267 tokens | Cum: 839 tkns (10.49% of 8k)
==========================================================================

Showing C6 (chunk 1 of 8): C6:
**Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA Platform**
Date: Jan-14-25 07:45AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/01/14/3009212/0/en/Firefly-Neuroscience-Discovers-Breakthrough-Cognitive-Brain-Age-Biomarker-Using-its-FDA-Cleared-BNA-Platform.html

January 14, 2025 07:45 ET| Source:Firefly Neuroscience, Inc.Firefly Neuroscience, Inc.

KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the advancement of research to assess a patient’s brain age - an estimation of the biological age of a person's brain – via its FDA-cleared BNA™ technology pl

-- More? (MOR) or Next section? (NEX)

AIFF_IN_4 [2025-03-20 11:45:03 -0400] 19 Bytes | 7 tokens | Cum: 846 tkns (10.57% of 8k)
==========================================================================

Next section? (NEX)

AIFF_OUT_5 [2025-03-20 11:45:05 -0400] 1039 Bytes | 312 tokens | Cum: 1158 tkns (14.47% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-14T17:05:44Z - 12 Health Care Stocks Moving In Friday's Intraday Session - Firefly Neuroscience (NASDAQ:AIFF), Acla...
A2 - 2025-03-06T12:40:03Z - Hemostemix Inc.: Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA) Engage to Compl...
A3 - 2025-03-06T12:35:12Z - Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 V...
A4 - 2025-03-06T12:34:21Z - Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 V...
A5 - 2025-03-04T20:50:01Z - February's 20 Most-Searched Tickers On Benzinga Pro - Where Do Tesla, Palantir, Alibaba, Nvidia Stoc...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

AIFF_IN_6 [2025-03-20 11:45:05 -0400] 2 Bytes | 2 tokens | Cum: 1160 tkns (14.50% of 8k)
==========================================================================

A1

AIFF_OUT_7 [2025-03-20 11:45:06 -0400] 967 Bytes | 293 tokens | Cum: 1453 tkns (18.16% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Friday's Intraday Session - Firefly Neuroscience (NASDAQ:AIFF), Aclarion (NASDAQ:ACON)**Date: 2025-03-14Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44336251/12-health-care-stocks-moving-in-fridays-intraday-sessionGainers Akebia Therapeutics AKBA shares rose 31.6% to $2.23 during Friday's regular session. The company's market cap stands at $485.4 million. The company's, Q4 earnings came out yesterday. Syros Pharmaceuticals SYRS stock rose 29.54% to $0.1. The company's market cap stands at $2.6 million. Biote BTMD stock increased by 24.59% to $3.83. The market value of their outstanding shares is at $119.0 million. As per the news, the Q4 earnings report came out 2 days ago. Firefly Neuroscience AIFF stock rose 20.52% to $4.17. The market value of their outstanding shares i

-- More? (MOR) or Next section? (NEX)

AIFF_IN_8 [2025-03-20 11:45:06 -0400] 3 Bytes | 2 tokens | Cum: 1455 tkns (18.19% of 8k)
==========================================================================

MOR

AIFF_OUT_9 [2025-03-20 11:45:07 -0400] 967 Bytes | 289 tokens | Cum: 1744 tkns (21.80% of 8k)
==========================================================================

Showing A1 (chunk 2 of 3): s at $33.6 million. Scienture Holdings SCNX stock moved upwards by 19.35% to $1.48. The market value of their outstanding shares is at $12.7 million. Aclarion ACON shares rose 17.88% to $0.81. Losers Sutro Biopharma STRO shares declined by 29.6% to $0.88 during Friday's regular session. The market value of their outstanding shares is at $72.5 million. NeueHealth NEUE stock declined by 28.08% to $4.76. The company's market cap stands at $39.4 million. Dogwood Therapeutics DWTX shares fell 23.29% to $5.93. The company's market cap stands at $7.8 million. Universe Pharmaceuticals UPC stock fell 17.64% to $0.1. The company's market cap stands at $1.5 million. Atlantic International ATLN shares decreased by 16.0% to $5.04. The market value of their outstanding shares is at $313.6 million. Polyrizon PLRZ shares decreased by 15.56% to $0.57. The market value of their outstanding shares is at $2

-- More? (MOR) or Next section? (NEX)

AIFF_IN_10 [2025-03-20 11:45:08 -0400] 13 Bytes | 3 tokens | Cum: 1747 tkns (21.84% of 8k)
==========================================================================

Next section.

AIFF_OUT_11 [2025-03-20 11:45:09 -0400] 1031 Bytes | 294 tokens | Cum: 2041 tkns (25.51% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-02-21T13:00:00Z - Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
B2 - 2025-02-11T12:45:00Z - Firefly Neuroscience Accepted into NVIDIA Connect Program
B3 - 2024-11-14T22:30:00Z - Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
B4 - 2024-11-08T07:34:00Z - 4 Biotech Stocks With AI, Machine Learning Prowess
B5 - 2024-08-26T13:00:00Z - Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright’s 26th Annual Global Investment Conference September 9-11
B6 - 2024-08-21T13:00:00Z - Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

AIFF_IN_12 [2025-03-20 11:45:09 -0400] 2 Bytes | 2 tokens | Cum: 2043 tkns (25.54% of 8k)
==========================================================================

B1

AIFF_OUT_13 [2025-03-20 11:45:16 -0400] 604 Bytes | 161 tokens | Cum: 2204 tkns (27.55% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/02/21/3030419/0/en/Firefly-Neuroscience-Announces-Exercise-of-Warrants-for-Total-Proceeds-of-8-8-Million.htmlFirefly Neuroscience, Inc. has received $8.8 million from the exercise of warrants, which will be used for general working capital purposes, including the development of its FDA-cleared Brain Network Analytics (BNA™) technology platform.

-- More? (MOR) or Next section? (NEX)

AIFF_IN_14 [2025-03-20 11:45:16 -0400] 815 Bytes | 140 tokens | Cum: 2344 tkns (29.30% of 8k)
==========================================================================

As a financial analyst, I would interpret this information to mean that Firefly Neuroscience, Inc. has increased its cash reserves by $8.8 million through the exercise of warrants. This extra capital will be channeled towards the company's general working capital needs, such as day-to-day operational expenses. A significant portion of this funding will likely be allocated towards the development of their Brain Network Analytics technology platform, which has already received clearance from the FDA. This financial boost could potentially accelerate the company's research and development activities, and help it to further consolidate its position within the neuroscience industry. It's also worth noting that the exercise of warrants indicates that investors see potential in the company's future performance.

AIFF_OUT_15 [2025-03-20 11:45:17 -0400] 1156 Bytes | 295 tokens | Cum: 2639 tkns (32.99% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S6 - 2024-12-23 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On December 20, 2024, Firefly Neuroscience, Inc., a Delaware corporation (the Company) entered into a definitive security purchase agreement (the SPA) with Helena Special Opportunities LLC (He...

S7 - 2024-12-23 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On December 20, 2024, Firefly Neuroscience, Inc., a Delaware corporation (the Company) entered into a definitive security purchase agreement (the SPA) with Helena Special Opportunities LLC (He...

S8 - 2024-12-23 8-K Item 1.01 Entry into a Material Definitive Agrmt.

Securities Purchase Agrmt

On December 20, 2024, Firefly Neuroscience, Inc., a Delaware corporation (the Company) entered into a definitive security purchase agreement (the SPA) with Helena Special Opportunities LLC (He...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

AIFF_IN_16 [2025-03-20 11:45:18 -0400] 2 Bytes | 2 tokens | Cum: 2641 tkns (33.01% of 8k)
==========================================================================

S6

AIFF_OUT_17 [2025-03-20 11:45:26 -0400] 967 Bytes | 228 tokens | Cum: 2869 tkns (35.86% of 8k)
==========================================================================

Showing S6 (chunk 1 of 6): S6:
Item 1.01 Entry into a Material Definitive Agreement.

Securities Purchase Agreement

On December 20, 2024, Firefly Neuroscience, Inc., a Delaware corporation (the Company) entered into a definitive security purchase agreement (the SPA) with Helena Special Opportunities LLC (Helena), an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor, providing for gross proceeds up to USD$2.4 million through a private placement (the Financing) for the issuance of a convertible promissory note (the Note).

The Note has an initial aggregate principal amount of USD$2.4 million (the Principal Amount), including an original issue discount (OID) of the Note of an aggregate USD$360,000, which shall be convertible into such number of shares of the common stock (Conversion Shares) of the Company, par value $0.0001 per share (the Common Stock) at the conversion price of $3.00,

-- More? (MOR) or Next section? (NEX)

AIFF_IN_18 [2025-03-20 11:45:26 -0400] 665 Bytes | 140 tokens | Cum: 3009 tkns (37.61% of 8k)
==========================================================================

The document refers to a material definitive agreement entered into by Firefly Neuroscience, Inc. (the Company) and Helena Special Opportunities LLC (Helena) on December 20, 2024. The agreement is a Securities Purchase Agreement (SPA), through which the Company will secure gross proceeds of up to USD$2.4 million via a private placement. This financing will be facilitated through the issuance of a convertible promissory note (the Note) with an initial aggregate principal amount of USD$2.4 million. This Note includes an original issue discount of USD$360,000 and is convertible into shares of the Company's common stock at a conversion price of $3.00 per share.

AIFF_OUT_19 [2025-03-20 11:45:41 -0400] 4675 Bytes | 1352 tokens | Cum: 4361 tkns (54.51% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| Volume: 1,194,405 | SMA50: 16.28% | Market Cap: 44.72M | Option/Short: No / Yes | Sales past 5Y: -2.34% | Sales Surprise: - |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| Avg Volume: 9.01M | SMA200: 21.75% | Shs Outstand: 8.48M | Short Float: 13.54% | Employees: 42 | EPS Surprise: - |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| Rel Volume: 0.39 | Perf Week: 60.13% | Shs Float: 3.30M | Short Ratio: 0.05 | Debt/Eq: 0.00 | P/E: - |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| RSI (14): 54.58 | Perf Month: -34.82% | Inst Own: 12.70% | Short Interest: 0.45M | Sales Y/Y TTM: -30.83% | Earnings: - |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| ATR (14): 1.12 | Perf Quarter: 87.82% | Insider Own: 59.13% | Beta: 3.19 | ROE: -66.59% | |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+
| SMA20: 19.82% | Index: - | Insider Trans: 0.00% | Sales Q/Q: -98.37% | ROI: -48.93% | |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Inside Trans: FIREFLY NEUROSCIENCE, INC. (AIFF) by Vnook Stella (Unknown Title) on 2025-03-10
- Deferred Stock Units: 16667 shares at $0 (D)

Inside Trans: FIREFLY NEUROSCIENCE, INC. (AIFF) by Krzywicki Paul (Chief Financial Officer) on 2025-03-10
- Restricted Stock Units: 10000 shares at $0 (D)
- Incentive Stock Option (Right to Buy): 15000 shares at $0 (D)

Inside Trans: FIREFLY NEUROSCIENCE, INC. (AIFF) by DeCaprio David (Unknown Title) on 2025-03-10
- Deferred Stock Units: 16667 shares at $0 (D)

Inside Trans: FIREFLY NEUROSCIENCE, INC. (AIFF) by POSNER BRIAN M (Unknown Title) on 2025-03-10
- Deferred Stock Units: 16667 shares at $0 (D)

Inside Trans: FIREFLY NEUROSCIENCE, INC. (AIFF) by Menawat Arun Swarup (Chairman) on 2025-03-10
- Deferred Stock Units: 16667 shares at $0 (D)

Now we've reached the end of the analysis.
You are now invited to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
Again, that is: 1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

[Company Financial Summary]
[Company Details]
Name: Firefly Neuroscience, Inc. Common Stock
Market Cap: 38904726.400000006
Shares Outstanding: 8071520
Sector: SERVICES-PREPACKAGED SOFTWARE

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 33000, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -4289000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 5.7796
Average Volume: 1883975.91
30-Day High: 8.5
30-Day Low: 3.12

[Detailed Financials: Q3 2024]
- Total Assets: $5,311,000.0
- Total Liabilities: $2,535,000.0
- Total Equity: $2,776,000.0
- Current Assets: $2,665,000.0
- Current Liabilities: $2,535,000.0

[Income Statement: Q3 2024]
- Revenue: $33,000
- Net Income: $-4,289,000.0
- Operating Income: $-4,268,000.0
- Earnings Per Share (EPS): -0.61

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: N/A
==== END OF FINANCIAL REPORT ====

AIFF_IN_20 [2025-03-20 11:45:41 -0400] 1150 Bytes | 242 tokens | Cum: 4603 tkns (57.54% of 8k)
==========================================================================

The performance metrics of Firefly Neuroscience Inc. indicate volatile and speculative trading. The weekly performance shows an impressive growth of 60.13% and the performance over the quarter is up by 87.82%. However, the monthly performance shows a significant drop of -34.82%. The company has a high relative volume of 0.39 and also a high beta of 3.19, indicating high volatility. The health of the company is concerning with sales over the past five years decreasing by 2.34% and the sales in the past year decreasing by a massive 30.83%. This is also reflected in the company's negative ROE and ROI. The company also has a high level of insider ownership at 59.13%, which could indicate confidence in the company's future prospects.

Inside transactions suggest that the key employees and stakeholders are being awarded equity in the company, which could further indicate confidence in the company's growth. However, the company's financial health and recent performance suggest a high level of uncertainty.

MARKET_SCORE[45]
PRICE_TARGET[$6.50]
AI_RPT_HEADLINE: "Firefly Neuroscience Displays Volatile Performance Amid Concerning Sales Drop"

AIFF_OUT_21 [2025-03-20 11:45:43 -0400] 561 Bytes | 131 tokens | Cum: 4734 tkns (59.17% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

AIFF_IN_22 [2025-03-20 11:45:43 -0400] 40 Bytes | 10 tokens | Cum: 4744 tkns (59.30% of 8k)
==========================================================================

-> X2 <- More SEC filings & insider data

AIFF_IN_23 [2025-03-20 11:45:43 -0400] 126 Bytes | 29 tokens | Cum: 4773 tkns (59.66% of 8k)
==========================================================================

====================================
[2025-03-20 08:45:43] # Analysis Completed
Elapsed Time: 46.78 seconds




Scroll to Top